ISA Pharma SRL
2.1 FTEThe score of ISA Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +47 % Total assets +12 % Headcount (avg FTE) +17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ISA Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 34,498 € | ||||
| Equity | 181,475 € | ||||
| Cash | 146,413 € | ||||
| EBITDA | 61,626 € | ||||
| Total assets | 346,253 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
- Year ended 31 Dec 2021filed on 10 Aug 2022
ISA Pharma's financial analysis
- Solvency52.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ISA Pharma
ISA Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0835.600.362
- VAT number
- BE0835600362
- Peppol
- Registered · 0208:0835600362 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Apr 2011
- Registered office
- 1350 Orp-Jauche
- Size
- Micro · 2.1 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ISA Pharma (SRL) has been based in Orp-Jauche since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 34,498 € and equity of 181,475 €; its revenue is not published. With 2.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 52.4%, above the median of its sector (41.5%).
Companies similar to ISA Pharma
Companies in the same business, of comparable size and area, outside its group.
- Almax Pharma Retail sale of pharmaceutical products Walcourt · balance sheet 346,656 €
- Apotheek Joye Retail sale of pharmaceutical products Kortrijk · balance sheet 346,818 €
- Immo Maeriën-Ghilain Retail sale of pharmaceutical products Kasterlee · balance sheet 348,075 €
- Kerckaert Pharma Retail sale of pharmaceutical products Lievegem · balance sheet 350,343 €
- Vemaco Retail sale of pharmaceutical products Kapelle-op-den-Bos · balance sheet 350,379 €
- Farma Florosa Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 350,389 €
- Sauveniere Retail sale of pharmaceutical products Saint-Gilles · balance sheet 351,330 €
- Nathypharm Retail sale of pharmaceutical products Andenne · balance sheet 340,634 €
Frequently asked questions about ISA Pharma
What is the revenue of ISA Pharma?
ISA Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ISA Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0835600362 for ISA Pharma, if the company is VAT-registered. Its company number (CBE) is 0835.600.362.
Where is the registered office of ISA Pharma?
According to the CBE register, the registered office of ISA Pharma is in 1350 Orp-Jauche.
What is the equity of ISA Pharma?
At the close of the 2025 financial year, the equity of ISA Pharma amounts to 181,475 €, a solvency of 52.4% of total assets.
How many people work at ISA Pharma?
2.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ISA Pharma?
The register lists 1 active mandates at ISA Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ISA Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →